Evidence map›Paper›PMID 40182595›Full record

ArticleWorld journal of gastroenterology2025

New insights into the mechanisms of modified

Ajitha G Gopika, Naresh Sachdeva

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ajitha G GopikaDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Naresh SachdevaDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. sachdeva.naresh@pgimer.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy-induced intestinal mucositis (IM) is a prevalent complication affecting up to 80% of cancer patients undergoing treatment. Current therapies focus on symptomatic relief rather than addressing the underlying mechanism. Recent advances in integrative medicine highlight the potential of traditional Chinese medicine formulations as alternatives or adjuncts to existing therapies. In this context, this editorial discusses the recent results of a study published by Qiu

Indexed as

Antineoplastic AgentsDrugs, Chinese HerbalIntestinal MucosaMucositisPulsatillaAnimalsCytokinesDiarrheaDisease Models, AnimalFluorouracilGastrointestinal MicrobiomeHumansMiceOxidative StressAntineoplastic AgentsCytokinesDrugs, Chinese HerbalFluorouracilGut microbiotaInflammatory responseIntestinal mucositisModified Pulsatilla decoctionOxidative stressTLR4/MyD88/nuclear factor kappa-B pathway

Identifiers

PMID40182595
PMCPMC11962847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.